
Shares of Teladoc Health, Inc. (NYSE:TDOC) shares are lower after the telemedicine company issued below-consensus guidance for the first quarter.
The Teladoc Analysts: Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc shares and reduced the price target from $170 to $100.